.svg){kind=small}
Sep-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Ilera Healthcare has shown notable performance in the Concentrates category within the state of Maryland. In September 2024, the brand secured the 24th position in the category rankings, marking its first appearance in the top 30 for this state and category over the observed months. This breakthrough suggests a positive trend in market penetration or consumer preference for Ilera Healthcare's products in Maryland. The absence of rankings in the previous months indicates that Ilera Healthcare was not among the leading brands in this category, which could imply either a prior lack of market presence or significant competition. Nonetheless, their entry into the top 30 in September signals a potential upward trajectory worth monitoring in the coming months.
While Ilera Healthcare's recent ranking in Maryland is a positive development, the lack of similar data from other states or categories suggests that the brand's presence may be limited or less competitive in regions outside Maryland's Concentrates market. This could be seen as an area for growth or a reflection of strategic focus on specific markets. The data also highlights the importance of regional strategies and consumer preferences in the cannabis industry, as success in one state does not necessarily translate to another. Observing how Ilera Healthcare leverages its position in Maryland to expand its reach or improve its standings in other markets could provide valuable insights into its strategic direction and adaptability in the evolving cannabis landscape.
Competitive Landscape
In the Maryland concentrates market, Ilera Healthcare has shown a notable entry into the competitive landscape by securing the 24th rank in August 2024. This marks a significant development as the brand was not in the top 20 in the preceding months, indicating a positive trajectory in market presence. However, Ilera Healthcare faces stiff competition from established brands such as Verano and District Cannabis, which have consistently maintained higher ranks, with Verano reaching 12th in June 2024 and District Cannabis holding 9th place in the same month. Despite these challenges, Ilera's emergence in the rankings suggests potential for growth, although it remains behind competitors like Avexia, which ranked 23rd in July 2024. The evolving dynamics in this sector highlight opportunities for Ilera Healthcare to leverage its recent momentum to enhance its market share and sales performance.
Notable Products
In September 2024, the top-performing product for Ilera Healthcare was the Indica Blend RSO Dablicator (1g) in the Concentrates category, maintaining its first-place ranking consistently from June through September, with a notable sales figure of 43 units. The Butter Mintz RSO Dablicator (1g) secured the second position, showing a steady performance throughout the months, with a slight dip in sales compared to August. The Butter Mintz Dablicator (1g) ranked third, experiencing a drop in sales from the previous month, where it held the second position. The Indica Live RSO Dablicator (1g) did not rank in September, having last appeared in the rankings in June. Overall, the top products demonstrated consistent performance, with minor shifts in rankings and sales figures over the months.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
